EXPRESSION OF CELL-MEMBRANE RECEPTORS FOR UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IN THE HUMAN ENDOMETRIUM INCREASES DURING THE OVARIAN CYCLE

被引:12
作者
CASSLEN, B [1 ]
GUSTAVSSON, B [1 ]
机构
[1] UNIV LUND,DEPT OBSTET & GYNECOL,S-22101 LUND,SWEDEN
关键词
UROKINASE RECEPTOR; CELL MEMBRANE; PLASMINOGEN ACTIVATOR; ENDOMETRIUM; UTERUS; ASSAY;
D O I
10.1016/0268-9499(91)90007-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human endometrial membranes were found to have binding sites for high molecular weight urokinase plasminogen activator (HMW-u-PA). The binding was characterised and assayed using I-125-HMW-u-PA. The results indicated a receptor, which was highly specific for HMW-u-PA, and that binding was saturable at low concentrations 1.4 (range 1.3-1.6) nmol/l. Scatchard analysis suggested a single class of binding sites with K(D) 1.1 (range 0.7-1.9) nmol/l. These binding data are similar to those reported in some cell types and cancer tissue. The amount of receptors in individual endometrial samples was assayed either directly, or after exposure of the membranes to pH 2. This treatment removed endogenously bound u-PA and allowed the total number of receptors to be measured. We found the total number of receptors to be higher in the secretory (235 +/- 46 fmol/mu-g protein) than the proliferative (98 +/- 16 fmol/mu-g protein) phase. This was reflected in free as well as occupied receptors. The percentage of occupied receptors was, however, 30-35% in both phases. The increased number of receptors presumably results from the combined action of estradiol and progesterone in the secretory phase.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 34 条
[1]   CRYPTIC UROKINASE BINDING-SITES ON HUMAN FORESKIN FIBROBLASTS [J].
BAJPAI, A ;
BAKER, JB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 133 (02) :475-482
[2]  
BOYD D, 1989, CANCER RES, V49, P2427
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   RECEPTOR FOR PLASMIN ON HUMAN CARCINOMA-CELLS [J].
BURTIN, P ;
FONDANECHE, MC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (10) :762-765
[5]  
CASSLEN B, 1986, P SOC EXP BIOL MED, V182, P419
[6]   EFFECT OF IUD ON UROKINASE-LIKE IMMUNOREACTIVITY AND PLASMINOGEN ACTIVATORS IN HUMAN UTERINE FLUID [J].
CASSLEN, B ;
THORELL, J ;
ASTEDT, B .
CONTRACEPTION, 1981, 23 (04) :435-445
[7]  
CASSLEN B, 1981, ACTA OBSTET GYN SCAN, V60, P97
[8]   OCCURRENCE OF BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN THE HUMAN-ENDOMETRIUM [J].
CASSLEN, B ;
ASTEDT, B .
CONTRACEPTION, 1983, 28 (06) :553-564
[9]   THE MR 17500 REGION OF THE A-CHAIN OF UROKINASE IS REQUIRED FOR INTERACTION WITH A SPECIFIC RECEPTOR IN A431 CELLS [J].
FIBBI, G ;
DINI, G ;
PASQUALI, F ;
PUCCI, M ;
DELROSSO, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 885 (03) :301-308
[10]   ESTROGEN-STIMULATED UPTAKE OF PLASMINOGEN BY THE MOUSE UTERUS [J].
FINLAY, TH ;
KATZ, J ;
KIRSCH, L ;
LEVITZ, M ;
NATHOO, SA ;
SEILER, S .
ENDOCRINOLOGY, 1983, 112 (03) :856-861